The data shown below were collected from the profiles of 79 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Ezetimibe for the prevention of cardiovascular disease and all‐cause mortality events
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2018
|
| DOI | 10.1002/14651858.cd012502.pub2 |
| Pubmed ID | |
| Authors |
Shipeng Zhan, Min Tang, Fang Liu, Peiyuan Xia, Maoqin Shu, Xiaojiao Wu |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 10 | 13% |
| United States | 5 | 6% |
| United Kingdom | 4 | 5% |
| Venezuela, Bolivarian Republic of | 1 | 1% |
| Colombia | 1 | 1% |
| Bolivia, Plurinational State of | 1 | 1% |
| Canada | 1 | 1% |
| Unknown | 56 | 71% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 63 | 80% |
| Practitioners (doctors, other healthcare professionals) | 9 | 11% |
| Scientists | 6 | 8% |
| Science communicators (journalists, bloggers, editors) | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 337 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 337 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 45 | 13% |
| Student > Bachelor | 40 | 12% |
| Researcher | 28 | 8% |
| Other | 20 | 6% |
| Student > Ph. D. Student | 17 | 5% |
| Other | 52 | 15% |
| Unknown | 135 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 85 | 25% |
| Nursing and Health Professions | 26 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 4% |
| Social Sciences | 11 | 3% |
| Unspecified | 11 | 3% |
| Other | 36 | 11% |
| Unknown | 156 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 44. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2024.
All research outputs
#980,575
of 26,154,283 outputs
Outputs from Cochrane database of systematic reviews
#1,816
of 13,187 outputs
Outputs of similar age
#21,387
of 451,016 outputs
Outputs of similar age from Cochrane database of systematic reviews
#56
of 237 outputs
Altmetric has tracked 26,154,283 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,187 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,016 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 237 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.